NEWS2023-07-21T18:38:51+00:00

Client News

  • Vero

Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals

VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that it is doubling down on its commitment to support the treatment of patients afflicted […]

April 8th, 2020|
  • Vero

FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases associated with the novel coronavirus1.  Click here for full press release

March 26th, 2020|

MCRC Newsletters

Client News

  • Vero

Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals

VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that it is doubling down on its commitment to support the treatment of patients afflicted [...]

April 8th, 2020|
  • Vero

FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases associated with the novel coronavirus1.  Click here for full press release

March 26th, 2020|

MCRC Newsletters

Go to Top